Potential for nevirapine resistance with single dosing?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1254, 2000-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalised medicine with genetic-guided warfarin dosing?

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Nevirapine unsafe for HIV-1 infection prophylaxis?

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Efavirenz and Nevirapine in HIV-1 Infection: Is There a Role for Clinical Pharmacokinetic Monitoring?

By Dahri Karen Ensom Mary H.H.

Clinical Pharmacokinetics, Vol. 46, Iss. 2, 2007-01 ,pp. : 109-132

Adis International

Access to resources Recommend Favorite

Resistance to antibacterial prescribing practice?

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Statins a potential treatment for osteoporosis?

Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite